Virginia · 90739

Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in Virginia

Virginia Medicare Avg
$147.84
1% above national avg
National Medicare Avg
$146.78
All states combined
Billed Charge (VA)
$254.44
What providers submit
Est. Commercial (VA)
$325.26
National avg: $328.79
Est. Cash / Self-Pay (VA)
$180.85
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

280
Services in VA
105
Providers
N/A
Min Payment
N/A
Max Payment

Virginia Pricing in Context

In Virginia, CPT code 90739 (Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use) carries an average Medicare payment of $147.84 — 1% above the national benchmark of $146.78. 105 providers across the state submitted claims for this procedure in 2023, performing 280 total services. Individual payments in VA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Virginia is $254.44, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Virginia sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in Virginia lands near $325.26, with self-pay cash prices typically around $180.85. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use cost in Virginia?

The average Medicare payment for Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in Virginia is $147.84, which is 1% above the national average of $146.78. Providers in VA typically bill $254.44 for this procedure.

What does Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use cost with insurance in Virginia?

With commercial insurance in Virginia, Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use costs an estimated $325.26. Without insurance, the estimated cash price is $180.85. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in Virginia?

105 providers in Virginia billed Medicare for Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use in 2023, performing 280 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use cheaper in Virginia than the national average?

No — Hepatitis B Vaccine (hepb), Cpg-Adjuvanted, Adult Dosage, 2 Dose Or 4 Dose Schedule, For Intramuscular Use costs 1% above the national average in Virginia. The state average Medicare payment is $147.84 compared to $146.78 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial